Temporal trends and projections of hypertension with hyperlipidemia-related mortality among US adults, 2000-2035: Insights from CDC WONDER database.
Abstract
Background
Hypertension and hyperlipidemia are highly prevalent cardiometabolic disorders and major contributors to cardiovascular morbidity and mortality. These conditions frequently coexist and synergistically increase cardiovascular risk through mechanisms including endothelial dysfunction, vascular inflammation, and atherosclerosis. Despite advances in treatment, many individuals remain inadequately controlled. This study evaluated temporal trends in mortality associated with hypertension and hyperlipidemia in the United States from 2000 to 2035.
Methods
A retrospective population-based analysis was conducted using the CDC WONDER Multiple Cause of Death database. Adults aged ≥25 years with hypertension (ICD-10: I10-I15) or hyperlipidemia (ICD-10: E78) listed on death certificates were included. Age-adjusted mortality rates (AAMRs) per 100,000 population were calculated using the 2000 U.S. standard population. Temporal trends were assessed using Joinpoint regression to estimate annual percent change (APC) and average annual percent change (AAPC). Analyses were stratified by sex, age, race/ethnicity, region, and urbanization.
Results
From 2000 to 2023, 1,156,335 deaths were recorded. AAMRs increased from 5.86 (95% CI: 5.74-5.97) to 37.28 (95% CI: 37.05-37.51), with a significant overall rise (AAPC: 8.34; p < 0.001). Mortality was consistently higher in males than females (AAPC: 8.50 vs. 7.93; both p < 0.001). All racial and ethnic groups showed increasing trends, with the highest mean AAMR among non-Hispanic Black individuals (AAPC: 8.21; p < 0.001). Older adults (≥65 years) had the greatest mortality burden (AAPC: 8.82; p < 0.001). The South (AAPC: 8.84; p<0.001) and non-metropolitan areas (AAPC: 9.76; p < 0.001) demonstrated the fastest-rising mortality rates.
Conclusion
Hypertension- and hyperlipidemia-related mortality rose substantially with marked disparities, highlighting the need for improved prevention and equitable care.